Cravens & Co Advisors »

Regeneron Pharmaceuticals shares owned by Cravens & Co Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Cravens & Co Advisors from 13F filings

Historical chart of Cravens & Co Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Cravens & Co Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Cravens & Co Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 1.3k 878.29
2023-09-30 $1.1M 1.3k 822.96
2023-06-30 $883k 1.2k 718.54
2023-03-31 $1.0M 1.2k 821.67
2022-12-31 $900k 1.2k 721.49

More positions owned by Cravens & Co Advisors

Smartfinancial Com New (SMBK)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Doubleline Etf Trust Opportunistic Bd (DBND)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Dimensional Etf Trust Intl Core Equity (DFIC)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Chevron Corporation (CVX)
Boeing Company (BA)
Netflix (NFLX)

View all positions for Cravens & Co Advisors

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Ubs Global Asset Management Americas
Charles Schwab Investment Management
Dimensional Fund Advisors

View all funds holding Regeneron Pharmaceuticals